FARMACIA Y SALUD
Escuela de doctorado
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (7)
2023
-
Cohort Profile: PISCIS, a population-based cohort of people living with HIV in Catalonia and Balearic Islands
International Journal of Epidemiology, Vol. 52, Núm. 4, pp. E241-E252
2020
-
Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease
United European Gastroenterology Journal, Vol. 8, Núm. 9, pp. 1056-1066
2019
-
Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients
Clinical and Translational Oncology, Vol. 21, Núm. 4, pp. 467-478
2018
-
Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: Multicentric study
Farmacia Hospitalaria, Vol. 42, Núm. 4, pp. 152-158
-
Recomendaciones de la Sociedad Española de Farmacia Hospitalaria, la Sociedad Española de Enfermería Oncológica y la Sociedad Española de Oncología Médica para el manejo seguro de la medicación antineoplásica del paciente con cáncer
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 42, Núm. 6, pp. 261-268
2015
-
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
Nature Genetics, Vol. 47, Núm. 2, pp. 164-171
2011
-
Population pharmacokinetics of lopinavir/ritonavir (kaletra) in HIV-infected patients
Therapeutic Drug Monitoring, Vol. 33, Núm. 5, pp. 573-582